$AGTX
Agentix Corp.

2024 Q1 Form 10-Q Financial Statement

#000147793224000711 Filed on February 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2022 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $103.2K $161.6K
YoY Change -36.17% 30.54%
% of Gross Profit
Research & Development -$87.30K $192.0K
YoY Change -145.46% 347.11%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $15.85K $353.6K
YoY Change -95.52% 112.08%
Operating Profit -$15.85K -$353.6K
YoY Change -95.52% 112.08%
Interest Expense $3.214K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$22.22K $0.00
YoY Change
Pretax Income $6.374K -$353.6K
YoY Change -101.8% 112.08%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $6.374K -$353.6K
YoY Change -101.8% 112.08%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 40.07M shares 40.07M shares 38.92M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.540K $3.480K $680.00
YoY Change -47.13% 411.76% -45.16%
Cash & Equivalents $6.535K $3.480K $679.00
Short-Term Investments
Other Short-Term Assets $99.84K $108.5K $110.8K
YoY Change -59.91% -2.1%
Inventory
Prepaid Expenses $99.84K $104.3K
Receivables
Other Receivables
Total Short-Term Assets $106.4K $112.0K $111.5K
YoY Change -59.31% 0.43% 119.98%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $106.4K $112.0K $111.5K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $106.4K $112.0K $111.5K
YoY Change -59.31% 0.43% 119.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $961.7K $1.106M $625.2K
YoY Change -60.77% 76.95% 417.7%
Accrued Expenses $23.82K $22.22K $100.00
YoY Change 161.42% 22121.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $143.0K $100.0K $0.00
YoY Change 186.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.667M $2.958M $1.975M
YoY Change 6.22% 49.8% 155.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.667M $2.958M $1.975M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.667M $2.958M $1.975M
YoY Change 6.22% 49.8% 155.4%
SHAREHOLDERS EQUITY
Retained Earnings -$5.954M -$5.951M -$4.938M
YoY Change 10.9% 20.52% 163.93%
Common Stock $40.07K $40.07K $39.12K
YoY Change 0.0% 2.43% 11.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.560M -$2.846M -$1.863M
YoY Change
Total Liabilities & Shareholders Equity $106.4K $112.0K $111.5K
YoY Change -59.31% 0.43% 119.98%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2022 Q4
OPERATING ACTIVITIES
Net Income $6.374K -$353.6K
YoY Change -101.8% 112.08%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$66.20K -$37.17K $200.00
YoY Change 60.29% -18685.0% -137.66%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 43.00K 50.00K 0.000
YoY Change -14.0%
NET CHANGE
Cash From Operating Activities -66.20K -37.17K 200.0
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 43.00K 50.00K 0.000
Net Change In Cash -23.20K 12.83K 200.0
YoY Change -366.67% 6315.0% -137.66%
FREE CASH FLOW
Cash From Operating Activities -$66.20K -$37.17K $200.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1615982 usd
us-gaap Professional Fees
ProfessionalFees
296673 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
527676 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
118273 usd
us-gaap Operating Expenses
OperatingExpenses
942622 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-942622 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
249023 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
261392 usd
CY2023Q1 us-gaap Assets
Assets
261392 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1057215 usd
CY2023Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
53535 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-770136 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-25434 usd
CY2022Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-409558 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2652473 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001603345
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40066951 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40066951 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40066951 shares
CY2023Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
357102 shares
CY2023Q4 us-gaap Financial Services Liabilities
FinancialServicesLiabilities
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55383
dei Entity Registrant Name
EntityRegistrantName
AGENTIX CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2876282
dei Entity Address Address Line1
EntityAddressAddressLine1
32932 Pacific Coast Highway
dei Entity Address Address Line2
EntityAddressAddressLine2
14-254
dei Entity Address City Or Town
EntityAddressCityOrTown
Dana Point
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92629
dei City Area Code
CityAreaCode
321
dei Local Phone Number
LocalPhoneNumber
299-2041
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40066931 shares
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12369 usd
CY2023Q1 agtx Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
1394230 usd
CY2023Q1 agtx Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
50000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9110 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2510555 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2510555 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40066951 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
40067 usd
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
357102 shares
CY2023Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
53535 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3025796 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
-13892 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
765 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5369326 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2249163 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
261392 usd
CY2023Q4 us-gaap Professional Fees
ProfessionalFees
78040 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
139821 usd
us-gaap Professional Fees
ProfessionalFees
315347 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
-87304 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
192032 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
129244 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25110 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21785 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
325545 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
15846 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
353638 usd
us-gaap Operating Expenses
OperatingExpenses
770136 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-15846 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-353638 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3212 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
3214 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
13851 usd
us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q4 agtx Interest Income
InterestIncome
0 usd
CY2022Q4 agtx Interest Income
InterestIncome
0 usd
agtx Interest Income
InterestIncome
-248 usd
agtx Interest Income
InterestIncome
0 usd
CY2023Q4 us-gaap Other Income
OtherIncome
0 usd
CY2022Q4 us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
-198371 usd
us-gaap Other Income
OtherIncome
0 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22220 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-187980 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
6374 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-353638 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-582156 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-942622 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
6374 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-353638 usd
us-gaap Net Income Loss
NetIncomeLoss
-582156 usd
us-gaap Net Income Loss
NetIncomeLoss
-942622 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-36889 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2225 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14657 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2225 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-30515 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-355863 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-596813 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-944847 usd
CY2023Q4 agtx Income Earnings Per Share Basic And Diluted
IncomeEarningsPerShareBasicAndDiluted
0.00
CY2022Q4 agtx Income Earnings Per Share Basic And Diluted
IncomeEarningsPerShareBasicAndDiluted
-0.01
agtx Income Earnings Per Share Basic And Diluted
IncomeEarningsPerShareBasicAndDiluted
-0.01
agtx Income Earnings Per Share Basic And Diluted
IncomeEarningsPerShareBasicAndDiluted
-0.02
CY2023Q4 agtx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
40066951 shares
CY2022Q4 agtx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
39116951 shares
agtx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
40066951 shares
agtx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
38995307 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2249163 usd
CY2023Q2 agtx Foreign Exchange Translation Loss
ForeignExchangeTranslationLoss
6248 usd
CY2023Q3 agtx Foreign Exchange Translation Loss
ForeignExchangeTranslationLoss
15984 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-178972 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-2815461 usd
CY2023Q4 agtx Foreign Exchange Translation Loss
ForeignExchangeTranslationLoss
-36889 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
6374 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-2845976 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1076998 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-164654 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1241652 usd
CY2022Q3 agtx Shares Issued For Cash Amount
SharesIssuedForCashAmount
50000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-424330 usd
CY2022Q4 agtx Shares Issued To Board Member For Services
SharesIssuedToBoardMemberForServices
30600 usd
CY2022Q4 agtx Shares Issued To Consultants For Services
SharesIssuedToConsultantsForServices
78075 usd
CY2022Q4 agtx Foreign Exchange Translation Loss
ForeignExchangeTranslationLoss
-2225 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-353638 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1863170 usd
us-gaap Profit Loss
ProfitLoss
582156 usd
us-gaap Profit Loss
ProfitLoss
942622 usd
agtx Amortization Of Stock Issued For Software
AmortizationOfStockIssuedForSoftware
23682 usd
agtx Amortization Of Stock Issued For Software
AmortizationOfStockIssuedForSoftware
15000 usd
agtx Stock Issued For Services
StockIssuedForServices
0 usd
agtx Stock Issued For Services
StockIssuedForServices
-108675 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-116869 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
109963 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
397373 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
881669 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-44232 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-47241 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
120000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
70000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-14657 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2225 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8889 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
534 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12369 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3480 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
679 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3480 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
104274 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
199347 usd
CY2023Q1 us-gaap Financial Services Liabilities
FinancialServicesLiabilities
21797 usd
CY2023Q4 agtx Shares Issued For Prepaid Software Value
SharesIssuedForPrepaidSoftwareValue
4197 usd
CY2023Q1 agtx Shares Issued For Prepaid Software Value
SharesIssuedForPrepaidSoftwareValue
27879 usd
CY2023Q1 agtx Notes Payable Related Party Current
NotesPayableRelatedPartyCurrent
50000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40066951 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
200000 shares
CY2022Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.25
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000 usd

Files In Submission

Name View Source Status
0001477932-24-000711-index-headers.html Edgar Link pending
0001477932-24-000711-index.html Edgar Link pending
0001477932-24-000711.txt Edgar Link pending
0001477932-24-000711-xbrl.zip Edgar Link pending
agtx-20231231.xsd Edgar Link pending
agtx_10q.htm Edgar Link pending
agtx_ex311.htm Edgar Link pending
agtx_ex312.htm Edgar Link pending
agtx_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
agtx-20231231_cal.xml Edgar Link unprocessable
agtx-20231231_def.xml Edgar Link unprocessable
agtx-20231231_lab.xml Edgar Link unprocessable
agtx-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
agtx_10q_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending